2022 – Aspen Pharmacare

Aspen delivers double digit organic growth in normalised EBITDA, operating profit and earnings

By Shauneen Beukes | Aug 31, 2022 |

Johannesburg – JSE-listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to report reviewed provisional Group financial results for the year ended 30 June 2022. SALIENT FEATURES Revenue from continuing operations increased by 2% (+5% in constant exchange rate (“CER”)) to R38,6 billion (FY2021: R37,8 billion); Normalised EBITDA from continuing operations…

Aspen concludes a collaboration agreement to manufacture and make available four Aspen-branded vaccines for Africa.

By Shauneen Beukes | Aug 31, 2022 |

Durban, South Africa – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to announce that one of its wholly-owned South African subsidiaries, Aspen SA Operations (Pty) Limited (“Aspen SA Operations”), has concluded a ten-year agreement (“the Agreement”) with Serum Institute of India Pvt Ltd (“the Serum Institute”), the world’s largest vaccine producer, for…

Aspen partners with HappiMe to support Jiyana Secondary School

By Shauneen Beukes | Aug 12, 2022 |

Johannesburg – Aspen Pharmacare, a leading global specialty and branded multinational pharmaceutical company, has donated 25 computers and 30 tablets to Jiyana Secondary School which produced one of the top performing students in Ekurhuleni in 2021. This donation forms part of the “Gender Equality Today for a Sustainable Tomorrow” program of the United Nations and…

Aspen’s response to Monkeypox being declared a Public Health Emergency of International Concern by WHO

By Shauneen Beukes | Jul 28, 2022 |

Durban – JSE listed company Aspen Pharmacare Holdings Limited (Aspen), a global multinational specialty pharmaceutical company, is positively positioned to respond as a third party for capacity fill opportunities following the World Health Organisation’s (WHO) declaration of monkeypox being a Public Health Emergency of International Concern (PHEIC). This declaration is the first since that announced…

Aspen hosts more than 800 Mandela Day activities over 12 years

By Shauneen Beukes | Jul 18, 2022 |

“Our purpose, To improve the health and quality of life of patients is closely aligned to the ethos of Mandela Day. This has been clearly demonstrated through our endeavours to provide citizens across the continent with vaccines which are manufactured in South Africa for Africa.” Durban – JSE Limited listed Aspen Pharmacare Holdings Limited…

Aspen donates life-saving surgical anaesthetics for about 240 000 Lebanese patients

By Shauneen Beukes | Jun 20, 2022 |

Aspen’s donation of anaesthetics to Lebanese patients Johannesburg, South Africa – Aspen Global Incorporated, a subsidiary of Pharmacare Limited, Africa’s largest pharmaceutical company, has donated a second supply of life-saving anaesthetics to Lebanon to facilitate surgical interventions to treat an additional 79 000 patients. This donation follows on Aspen’s donation of anaesthetics and oncology products…

Aspen presented with prestigious SAIC Business Award

By Shauneen Beukes | Mar 25, 2022 |

Johannesburg, South Africa – Aspen Pharmacare, a global specialty and branded pharmaceutical company was honoured at the 4th South African Investment Conference (“SAIC”) when it was presented with an award, by South African President Mr Cyril Ramaphosa, recognising Companies that Best Responded to the Challenges of the COVID Environment. The award acknowledges the role that…

Aspen announces R500 million investment at 4th SAIC

By Shauneen Beukes | Mar 24, 2022 |

Johannesburg, South Africa – Aspen Pharmacare, a global specialty and branded pharmaceutical company and Africa’s largest pharmaceutical company, has announced a further investment of some R500 million to its flagship pharmaceutical manufacturing site in Gqeberha. The announcement comes in the wake of more than R8 billion which Aspen has already invested in this world…

Aspen donates life-saving medicines for 62000 surgeries in Ukraine

By Shauneen Beukes | Mar 23, 2022 |

Johannesburg, South Africa – Aspen Pharmacare, Africa’s largest pharmaceutical company, has extended its support to Ukraine with donations of life-saving medicines required for urgent surgical intervention. This action further demonstrates Aspen’s ongoing commitment to saving lives and improving the quality of life of patients irrespective of their location or circumstances. Stavros Nicolaou Aspen Senior Executive…

Aspen helps evacuate SA students stranded in the Ukraine

By Shauneen Beukes | Mar 10, 2022 |

Aspen partners with South African Government to evacuate South African Student’s from the Ukraine conflict Johannesburg, South Africa – Aspen Pharmacare, Africa’s largest pharmaceutical company, has partnered with the South African Department of International Relations and Cooperation (“DIRCO”) to assist in the emergency evacuation of South African students who have been studying at various Universities…

Aspen delivers double digit organic revenue grown in constant exchange rates

By Shauneen Beukes | Mar 9, 2022 |

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced unaudited interim financial results for the six months ended 31 December 2021. SALIENT RESULTS Aspen reported the following salient results: Revenue from continuing operations increased by 4% (+10% in constant exchange rate (“CER”) to R19,4 billion…

Aspen concludes agreement to manufacture and make available an Aspen-branded COVID-19 vaccine (Aspenovax) throughout Africa

By Shauneen Beukes | Mar 8, 2022 |

“With the conclusion of this agreement, our vision for Africa’s own vaccine has become a reality,” said Stephen Saad, Aspen Group Chief Executive.